ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04727	GABAergic synapse	16/125	110/7206	4.51304830381e-11
ko05033	Nicotine addiction	11/125	56/7206	2.11276379953e-09
ko05032	Morphine addiction	13/125	110/7206	4.39030536751e-08
ko04740	Olfactory transduction	10/125	80/7206	1.01415387952e-06
ko04723	Retrograde endocannabinoid signaling	14/125	175/7206	1.72699045661e-06
ko04080	Neuroactive ligand-receptor interaction	22/125	423/7206	2.85703322664e-06
ko04724	Glutamatergic synapse	12/125	152/7206	1.13804055888e-05
ko04744	Phototransduction	6/125	36/7206	3.07225969848e-05
ko04742	Taste transduction	7/125	61/7206	8.00888810429e-05
ko04728	Dopaminergic synapse	12/125	185/7206	8.0399342525e-05
ko04725	Cholinergic synapse	11/125	160/7206	9.59258576648e-05
ko04713	Circadian entrainment	10/125	136/7206	0.000115482159811
ko04974	Protein digestion and absorption	8/125	96/7206	0.000242253505194
ko05014	Amyotrophic lateral sclerosis (ALS)	7/125	74/7206	0.00027419946643
ko04726	Serotonergic synapse	9/125	137/7206	0.000590342028477
ko04978	Mineral absorption	4/125	40/7206	0.00486726756982
ko05030	Cocaine addiction	5/125	73/7206	0.00850344949352
ko04721	Synaptic vesicle cycle	5/125	80/7206	0.0123695300156
ko05031	Amphetamine addiction	5/125	91/7206	0.0206036176376
ko00430	Taurine and hypotaurine metabolism	2/125	14/7206	0.023704409137
ko02024	Quorum sensing	2/125	15/7206	0.0270449846136
ko04024	cAMP signaling pathway	10/125	279/7206	0.029625147659
ko01051	Biosynthesis of ansamycins	1/125	2/7206	0.0343947704926
ko04730	Long-term depression	4/125	78/7206	0.0460846465465
ko04512	ECM-receptor interaction	4/125	79/7206	0.0479155280553